🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary endpoint is to determine if ECP induces a decrease in % of tumo...
Status
Recruiting
Location
Emory University School of Medicine
Start Date
2023-04-04
Trial ID
NCT05157581
Treatments Being Tested
COPERNIC is an international, multicentre, single-arm study. Chemo-refracto...
Status
Completed
Location
Institut Jules Bordet
Start Date
2023-10-12
Trial ID
NCT05487248
Treatments Being Tested
Phase II, randomized, double-blind, placebo-controlled study of the safety ...
Status
Completed
Location
National Taiwan University Hospital
Start Date
2018-10-15
Trial ID
NCT04133987
Treatments Being Tested
Children with diabetic ketoacidosis risk neurological complications such as...
Status
Completed
Location
University hospital Montpellier
Start Date
2016-10-03
Trial ID
NCT02994316
Treatments Being Tested
Neutropenia, a condition characterized by an abnormally low number of infec...
Status
Completed
Location
University of Iowa Hospitals and Clinics
Start Date
2008-04
Trial ID
NCT00627393
Treatments Being Tested
To assess the efficacy and safety of Human coronavirus immune plasma (HCIP)...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2020-06-03
Trial ID
NCT04373460
Treatments Being Tested
The purpose of this study is to collect blood samples from pregnant women w...
Status
Completed
Location
Natera, Inc
Start Date
2012-02
Trial ID
NCT01546324
Treatments Being Tested
Ceftobiprole, a fifth-generation cephalosporin, exhibits potent antibacteri...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-09-12
Trial ID
NCT07127185
Treatments Being Tested
This prospective study will research the exposure and its variability to fl...
Status
Completed
Location
UZ Leuven
Start Date
2019-04-23
Trial ID
NCT04252027
Treatments Being Tested
The study will begin with a two-week lead-in period (W-2 and W-1), when par...
Status
Recruiting
Location
RDSS Research Center
Start Date
2023-07-20
Trial ID
NCT06676410
Treatments Being Tested